Loading…
Biofil Chemicals & Pharmaceuticals (BIOFILCHEM)₹30.51−1.36%Pharmaceuticals
At the end of the Jun 2026 quarter, Biofil Chemicals & Pharmaceuticals' shareholders were: promoters 46.78%, DIIs 0.08%, public 53.14%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 25,010 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.81% | 46.81% | 46.81% | 46.81% | 46.81% | 46.81% | 46.81% | 46.81% | 46.78% | 46.78% | 46.78% | 46.78% |
| FIIs | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
| Public | 53.11% | 53.11% | 53.08% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.14% | 53.14% | 53.14% | 53.14% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 26,134 | 25,875 | 26,592 | 25,491 | 26,433 | 26,125 | 25,925 | 25,696 | 25,207 | 24,836 | 25,367 | 25,010 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Scope Finance Company Private Limited | Promoter | 13.89% | 0.00 |
| Mid (India) Pharmaceuticals Pvt Ltd | Promoter | 7.21% | 0.00 |
| Starline Equifin Private Limited | Public | 7.02% | −0.44 |
| Cyano Finance And Sales Pvt. Ltd. | Promoter | 5.43% | 0.00 |
| Niyati Shah | Promoter | 4.07% | 0.00 |
| Meena Shah | Promoter | 4.02% | 0.00 |
| Ketan Shah | Promoter | 3.02% | 0.00 |
| Sandeep Shah | Promoter | 2.61% | 0.00 |
| Romil Shah | Promoter | 2.33% | 0.00 |
| Ksl And Industries Limited | Public | 1.88% | 0.00 |
| Kishor Himmatsinh Jhala | Public | 1.23% | 0.00 |
| Smitesh Sanalal Shah | Promoter | 1.14% | 0.00 |
| Gom Industries Ltd | Public | 1.12% | 0.00 |
| Trupti Shah | Promoter | 0.64% | 0.00 |
| Manali Simon | Promoter | 0.54% | 0.00 |
| Meet Shah | Promoter | 0.54% | 0.00 |
| Ritu Shah | Promoter | 0.54% | 0.00 |
| Rohan Shah | Promoter | 0.40% | 0.00 |
| Kiran Shah | Promoter | 0.39% | 0.00 |
Promoters held 46.78% of Biofil Chemicals & Pharmaceuticals at the end of the Jun 2026 quarter, down 0.03 percentage points from 46.81% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.08% (unchanged at 0.08% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Biofil Chemicals & Pharmaceuticals had 25,010 shareholders at the end of the Jun 2026 quarter, against 25,696 a year earlier.
Starline Equifin Private Limited (Public) held 7.02% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.